Qsymia for weight loss is one of the most prescribed FDA-approved medications for chronic weight management, with patients typically losing 10 to 12% of starting body weight over 12 months, which is significantly higher than most older weight loss drugs and second only to the newer GLP-1 medications like semaglutide and tirzepatide
Metabolic disease can dull this axis and degrade sperm quality
A landmark study demonstrated gut microbiome diversity decreased activation across four major immune cell types (CD4+ T cells, CD8+ T cells, B cells, and monocytes), alongside reductions in 19 circulating inflammatory proteins, including IL-6
The data, to date, provide early indications of the potential of controlled intake, through supplementation, of these compounds
Inside the gut, different types of peptides can be released to signal to the rest of the body that certain events are occurring (such as detecting when food is coming into the intestine)